Showing results (1-10 of 168) with videos related to
Sort By:
Pageof 17
Current HIV Research|March 11, 2014
HIV-1 Rev multimerization: mechanism and insightsThomas Vercruysse, Dirk DaelemansPlos Genetics|February 12, 2021
Intermedilysin cytolytic activity depends on heparan sulfates and membrane compositionGediminas Drabavicius, Dirk DaelemansCurrent Opinion in HIV and AIDS|April 18, 2009
HIV-1 Rev function as target for antiretroviral drug developmentDirk Daelemans, Christophe PannecouqueNature Protocols|March 8, 2008
Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years laterChristophe Pannecouque, Dirk Daelemans, Erik De ClercqMethods in Molecular Biology (Clifton, N.J.)|October 28, 2021
Target Identification of Small Molecules Using Large-Scale CRISPR-Cas Mutagenesis Scanning of Essential GenesBert Kwanten, Jasper Edgar Neggers, Dirk DaelemansBioorganic & Medicinal Chemistry Letters|April 22, 2019
Xylo-C-nucleosides with a pyrrolo[2,1-f][1,2,4]triazin-4-amine heterocyclic base: Synthesis and antiproliferative propertiesPeng Nie, Elisabetta Groaz, Dirk Daelemans, et al.The Journal of Organic Chemistry|December 21, 2019
Iron/Copper Co-Catalyzed Cross-Coupling Reaction for the Synthesis of 6-Substituted 7-Deazapurines and the Corresponding NucleosidesQingfeng Li, Leentje Persoons, Dirk Daelemans, et al.Nature Microbiology|September 2, 2021
Cellular host factors for SARS-CoV-2 infectionJim Baggen, Els Vanstreels, Sander Jansen, et al.Journal of Virology|February 9, 2007
Characterization of a replication-competent, integrase-defective human immunodeficiency virus (HIV)/simian virus 40 chimera as a powerful tool for the discovery and validation of HIV integrase inhibitorsDirk Daelemans, Richard Lu, Erik De Clercq, et al.Nature Protocols|June 4, 2011
A time-of-drug addition approach to target identification of antiviral compoundsDirk Daelemans, Rudi Pauwels, Erik De Clercq, et al.Pageof 17